Cargando…

Cost-effectiveness of Human Papilloma Virus (HPV) vaccination in Nigeria: a decision analysis using pragmatic parameter estimates for cost and programme coverage

BACKGROUND: World Health Organisation recommends routine Human Papilloma Virus (HPV) vaccination for girls when its cost-effectiveness in the country or region has been duly considered. We therefore aimed to evaluate cost-effectiveness of HPV vaccination in Nigeria using pragmatic parameter estimate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ekwunife, Obinna I., Lhachimi, Stefan K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721469/ https://www.ncbi.nlm.nih.gov/pubmed/29216880 http://dx.doi.org/10.1186/s12913-017-2758-2

Ejemplares similares

Assessing cost-effectiveness of HPV vaccines with decision analytic models: what are the distinct challenges of low- and middle-income countries? A protocol for a systematic review
por: Ekwunife, Obinna I., et al.
Publicado: (2015)

Challenges in Cost-Effectiveness Analysis Modelling of HPV Vaccines in Low- and Middle-Income Countries: A Systematic Review and Practice Recommendations
por: Ekwunife, Obinna I., et al.
Publicado: (2016)

Cost-effectiveness analysis of diarrhoea management approaches in Nigeria: A decision analytical model
por: Okafor, Charles E., et al.
Publicado: (2017)

Cost-utility analysis of antihypertensive medications in Nigeria: a decision analysis
por: Ekwunife, Obinna Ikechukwu, et al.
Publicado: (2013)

An Evaluation of the Cost of Human Papilloma Virus (HPV) Vaccine Delivery In Zambia
por: Simuyemba, Moses C, et al.
Publicado: (2023)

Systematic reviews as a “lens of evidence”: Determinants of cost‐effectiveness of breast cancer screening
por: Mandrik, Olena, et al.
Publicado: (2019)

Mothers’ willingness to pay for HPV vaccines in Anambra state, Nigeria: a cross sectional contingent valuation study
por: Umeh, Ifeoma Blessing, et al.
Publicado: (2016)

Repurposed therapeutic agents targeting the Ebola virus: a protocol for a systematic review
por: Sweiti, Hussein, et al.
Publicado: (2015)

Repurposed Therapeutic Agents Targeting the Ebola Virus: A Systematic Review
por: Sweiti, Hussein, et al.
Publicado: (2017)

Introducing rotavirus vaccine in eight sub-Saharan African countries: a cost–benefit analysis
por: Okafor, Charles E, et al.
Publicado: (2021)

Cost-Effectiveness Evaluation of Quadrivalent Human Papilloma Virus Vaccine for HPV-Related Disease in Iran
por: Khatibi, Mohsen, et al.
Publicado: (2014)

Was the Maternal Health Cash Transfer Programme in Nigeria Sustainable and Cost-Effective?
por: Onwujekwe, Obinna, et al.
Publicado: (2020)

Promoting the integrated community case management of pneumonia in children under 5 years in Nigeria through the proprietary and patent medicine vendors: a cost-effectiveness analysis
por: Okafor, Charles E., et al.
Publicado: (2021)

Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria
por: Boiron, L., et al.
Publicado: (2016)

The patent buyout price for human papilloma virus (HPV) vaccine and the ratio of R&D costs to the patent value
por: Songane, Mario, et al.
Publicado: (2021)

What determines the effects and costs of breast cancer screening? A protocol of a systematic review of reviews
por: Mandrik, O., et al.
Publicado: (2017)

Cost benefit analysis of malaria rapid diagnostic test: the perspective of Nigerian community pharmacists
por: Ezennia, Ifeoma Jovita, et al.
Publicado: (2017)

Increasing HPV vaccination coverage to prevent oropharyngeal cancer: A cost-effectiveness analysis
por: Choi, Sung Eun, et al.
Publicado: (2021)

Incorporating economies of scale in the cost estimation in economic evaluation of PCV and HPV vaccination programmes in the Philippines: a game changer?
por: Suwanthawornkul, Thanthima, et al.
Publicado: (2018)

Cost-effectiveness and feasibility of conditional economic incentives and motivational interviewing to improve HIV health outcomes of adolescents living with HIV in Anambra State, Nigeria
por: Ekwunife, Obinna Ikechukwu, et al.
Publicado: (2021)

Costs associated with delivering HPV vaccination in the context of the first year demonstration programme in southern Mozambique
por: Alonso, Sergi, et al.
Publicado: (2019)

Assessment of attitudes of University of Nigeria pharmacy students toward pharmaceutical care
por: Udeogaranya, Patrick O., et al.
Publicado: (2009)

Governance of tuberculosis control programme in Nigeria
por: Ogbuabor, Daniel Chukwuemeka, et al.
Publicado: (2019)

Cost optimisation analysis of the expanded programme for immunisation: balancing equity and coverage in Pakistan
por: Houdroge, Farah, et al.
Publicado: (2022)

Estimating the epidemiological impact and cost-effectiveness profile of a nonavalent HPV vaccine in Spain
por: De La Fuente, Jesús, et al.
Publicado: (2019)

Impact of point-of-care C-reactive protein testing intervention on non-prescription dispensing of antibiotics for respiratory tract infections in private community pharmacies in Nigeria: a cluster randomized controlled trial
por: Onwunduba, Augustine, et al.
Publicado: (2023)

Cost-Effectiveness Analysis of Three Leprosy Case Detection Methods in Northern Nigeria
por: Ezenduka, Charles, et al.
Publicado: (2012)

Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer
por: Anyakora, Chimezie, et al.
Publicado: (2017)

The incremental cost of improving immunization coverage in India through the Intensified Mission Indradhanush programme
por: Chatterjee, Susmita, et al.
Publicado: (2021)

Estimating long-term clinical effectiveness and cost-effectiveness of HPV 16/18 vaccine in China
por: Zhang, Qian, et al.
Publicado: (2016)

Public knowledge and attitudes towards Human Papilloma Virus (HPV) vaccination
por: Walsh, Charlotte Devereaux, et al.
Publicado: (2008)

The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting
por: Kim, J J, et al.
Publicado: (2007)

Provisional Estimate of the Total Cost of the 300 GeV Programme
Publicado: (1979)

Development of Antibodies against HPV-6 and HPV-11 for the Study of Laryngeal Papilloma
por: Ikegami, Taro, et al.
Publicado: (2021)

Costing universal health coverage
por: Wong, Joseph, et al.
Publicado: (2019)

Knowledge of Cervical Cancer, Human Papilloma Virus (HPV) and HPV Vaccination Among Women in Northeast China
por: Ning, Yu-e, et al.
Publicado: (2019)

Knowledge of human papilloma virus (HPV), HPV-vaccine and pap smear among adult Saudi women
por: Al Ghamdi, Nada H.
Publicado: (2022)

Individual and socioeconomic factors associated with childhood immunization coverage in Nigeria
por: Oleribe, Obinna, et al.
Publicado: (2017)

Comparative cost analysis of cervical cancer screening programme based on molecular detection of HPV in Spain
por: Ibáñez, R., et al.
Publicado: (2021)

Evaluating the sensitivity of EQ-5D in a sample of patients with type 2 diabetes mellitus in two tertiary health care facilities in Nigeria
por: Ekwunife, Obinna Ikechukwu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9811tlcrva1ssc5pphnr54lr3c